...
首页> 外文期刊>Journal of Gastrointestinal Oncology >Mucinous adenocarcinoma arising from chronic perianal fistula—a multidisciplinary approach
【24h】

Mucinous adenocarcinoma arising from chronic perianal fistula—a multidisciplinary approach

机译:慢性肛周瘘引起的粘液腺癌-多学科研究

获取原文

摘要

Mucinous adenocarcinoma (MA) is a rare entity. Indeed, the pathogenesis of fistula-associated perianal MA is still controversial. Due to the lack of informed evidence regarding this malignancy, no guidelines have been established concerning diagnostic and treatment strategies. The aim of this article is to report our experience and outcomes after three cases of large perianal MA treated in our center. From our retrospective chart review, we identified three male patients with chronic perianal fistula-in-ano who progressively developed perianal MA, confirmed by pelvic magnetic resonance (MRI) and histopathological examination performed on biopsy. We hereby, in accordance with the Surgical CAse REport (SCARE) guidelines, describe the management and further follow-up of each patient. The three patients underwent preoperative chemoradiation therapy, followed by ischioanal abdominoperineal resection (APR). Perineal reconstruction was needed in every case, using a vertical rectus abdominis myocutaneous (VRAM) flap and, punctually, a left fasciocutaneous flap was used too. Also, two of three patients completed the treatment with adjuvant chemotherapy. Neither recurrences nor distant metastases have been observed during the follow-up in both cases that finished the multimodal treatment. MA arising from chronic perianal fistula has an indolent growth with locoregional aggressiveness and a high risk of local recurrence. Therefore, although an ischioanal APR remains the surgical treatment of choice, an aggressive multimodal approach combining preoperative chemoradiation and adjuvant chemotherapy may achieve favorable effectiveness and promising response rates.
机译:粘液腺癌(MA)是一种罕见的实体。的确,与瘘管相关的肛周MA的发病机制仍存在争议。由于缺乏有关这种恶性肿瘤的知情证据,因此尚未建立有关诊断和治疗策略的指南。本文的目的是报告在我们中心接受三例大肛周MA治疗后的经验和结果。从我们的回顾性图表审查中,我们确定了三名患有慢性肛周肛瘘的男性患者,这些患者逐渐发展为肛周MA,并经骨盆磁共振(MRI)和活检组织病理学检查证实。在此,我们根据手术病例报告(SCARE)指南,描述每位患者的治疗和进一步随访。这三名患者接受了术前放化疗,然后进行了等位腹部手术切除(APR)。在每种情况下,都需要使用垂直腹直肌肌皮瓣(VRAM)进行会阴重建,并且在必要时还使用左筋膜皮瓣。此外,三分之二的患者完成了辅助化疗的治疗。在完成多式联运治疗的两种情况下,随访期间均未观察到复发或远处转移。慢性肛周瘘引起的MA呈惰性生长,局部区域侵袭性高,局部复发风险高。因此,尽管缺血性APR仍然是首选的外科治疗方法,但结合术前放化疗和辅助化疗的积极多模式方法可能会获得良好的疗效和有希望的缓解率。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号